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Introduction 
An increase in the incidence of non-Hodgkin’s 
lymphoma (NHL) among human immunodeficiency 
virus (HIV) infected persons has been documented 
in various epidemiological studies (1,2). Wide- 
spread disease at the time of diagnosis is con- 
sidered a characteristic feature of HIV-related 
lymphomas. This case report describes an acquired 
immunodeficiency syndrome (AIDS) patient 
with multiple endobronchial disease secondary to 
NHL. 
Case Report 
A 35-year-old HIV positive woman with no prior 
history of opportunistic infections was admitted with 
new onset of generalized tonic clonic seizure. The 
diagnosis of HIV infection was made in 1990, 4 yr 
prior to this admission. She presumably acquired the 
HIV infection from heterosexual contact. Her last 
absolute count of CD4-positive lymphocytes was 
10 mm - 3. In the emergency department, her mental 
status recovered slowly without obvious residual 
neurologic deficit. The patient denied any history of 
illicit drug abuse or suicide attempts. Upon review of 
system, she admitted to having a non-productive 
cough for the past 4 weeks, night sweats and low 
grade fever. She had no haemoptysis, wheezing, or 
chest pain. She had never smoked and gave no 
history of travel outside Western New York. She had 
not been skin-tested recently or received chemo- 
prophylaxis for tuberculosis before. She was taking 
trimethropim-sulphamethoxazole and rifabutin for 
Pneumocystis carinii pneumonia (PCP) and Myco- 
bacterium avium intracellulare prophylaxis. 
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Her physical examination revealed a well devel- 
oped female, alert and oriented. Her temperature was 
100.2”F, blood pressure was 132/70 mmHg, and pulse 
rate was 72 beats min - ‘. Funduscopic examination 
revealed no papilledema and chest examination was 
unremarkable. There was no evidence of peripheral 
lymphadenopathy. Her neurologic examination 
failed to detect any focal deficit. Laboratory data 
were significant for haemoglobin of 9.6 g dl - ’ , hae- 
matocrit of 30.2%, white cell count of 2.7 mm ~ 3 and 
platelet count of 263 mm-‘. Electrolyte panel, cal- 
cium, magnesium and liver function tests were within 
normal limits. The IgG titer to toxoplasmosis by 
indirect fluorescent antibody was 128 (normal less 
than 10). Computed tomographic (CT) scan of the 
head revealed three nodular densities with rim of 
contrast enhancement located in the frontoparietal 
region with slight midline shift to the left. An antero- 
posterior chest roentgenogram showed a density in 
the right hilar region with normal surrounding lung 
fields (Plate 1). Considering the multiplicity of the 
CNS lesions and the elevated toxoplasma titer, the 
patient was started empirically on pyrimethamine 
and clindamycin for presumed CNS toxoplasmosis. 
A CT scan of the chest revealed a perihilar infil- 
trate in the right lung with irregular margin. The left 
lung was clear. There was no evidence of mediastinal 
adenopathy or vascular abnormalities (Plate 2). Spu- 
tum induced for PCP and sputum smear for acid-fast 
bacilli were negative on three separate occasions. 
Fiberoptic bronchoscopy was performed. A friable 
constricting lesion was noted in the mid-left main 
bronchus obscuring the distal airways. The mucosa 
in the vicinity of the lesion appeared normal. The 
right upper lobe bronchus was not clearly demar- 
cated due to a large exophytic lesion, richly vascular, 
that showed comparable characteristics to the lesion 
seen on the left side. Biopsies from both lesions 
revealed diffuse, large cell type, malignant lymphoma 
[International working formula (IWF)] with foci of 
extensive necrosis (Plate 3). Immunohistochemical 
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Plate I Posteroanterior chest roentgenograms revealing 
the presence of a right hilar density with normal lung fields. 
Plate 2 Chest computed tomographic (CT) scan shows a 
right hilar density with perihilar infiltrate in the absence of 
mediastinal adenopathy. 
assays revealed positive staining of the large tumour 
cells for the B-cell marker L26 (CD20) indicating a 
malignant B-cell lymphoma. 
The patient’s condition remained stable without 
recurrence of seizure activity. A repeat CT scan of the 
head, after 2 weeks of therapy for toxoplasmosis, 
demonstrated no improvement in the size or the 
number of the lesions. A right frontal stereotactic 
brain biopsy was then performed which revealed 
a large cell malignant lymphoma similar to the 
bronchial biopsies. 
Plate 3 Section of the left endobronchial biopsy showing 
large lymphocytes with coarse chromatin and inclusion-like 
macronuclei for B-cell marker. 
The patient was referred to Roswell Park Cancer 
Institute for further evaluation. The patient had a CT 
of abdomen and pelvis, bone marrow biopsy and a 
total body gallium imaging study as part of the 
staging process. A CT scan of the abdomen and 
pelvis revealed no lymphadenopathy or hepato- 
splenomegaly. The bone marrow biopsy was negative 
for lymphoma. Gallium scan showed increased accu- 
mulation in the frontoparietal region of the head, 
otherwise the tracer distribution was unremarkable. 
The patient received whole-brain radiation totalling 
3000 cGy and was started subsequently on the CHOP 
(Cytoxan, Adriamycin, Vincristine and Decadron) 
regimen. 
Discussion 
Non-Hodgkin’s lymphomas are the second most 
common malignancies in patients infected with the 
human immunodeficiency virus type I (HIV-l), after 
Kaposi’s sarcoma. Data from two New York City 
hospitals collected between 1980-1987 revealed a 
194-fold increase in the incidence of lymphoma 
in AIDS patients as compared to the age and 
sex-matched population (2). 
AIDS-related lymphomas share common patho- 
logic features, in that the majority are of the B-cell 
varieties. The predominant histologic picture consists 
of high grade B-cell lymphomas either of small 
non-cleaved cells typical of Burkitt’s or Burkitt-like 
lymphoma, or of immunoblastic cells with plasma- 
cytic features (3). Intermediate grade cell lymphomas 
are relatively less common, nevertheless, a 6.9-fold 
increase has been noted between 1979 -1987 (4). 
Pederson et al. (5) in a review of 51 AIDS patients, 
noted that 25% of NHL were of the diffuse, large cell, 
intermediate grade cell lymphomas, a histopathology 
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resembling the case under discussion. Rabkin et al. 
(6) reported similar findings in HIV-infected haemo- 
philiac patients with NHL. Extranodal sites are fre- 
quently involved in this group of patients at the time 
of initial presentation (5684% of reported cases 
compared to 40% incidence in non-HIV-related lym- 
phoma). Central nervous system, gastrointestinal 
tract, bone marrow and liver are among the most 
common sites involved (7). 
Pulmonary involvement by NHL is considered a 
relatively rare condition. In the earliest series, Ziegler 
et al. (7) reported a 9% incidence of lung involvement 
out of 90 homosexual men with NHL. According to 
most recent studies, the incidence varies between 
O-25% (8). Endobronchial lymphoma in HIV- 
infected persons has been described in two previous 
case reports (9,lO). In both cases, the lesions were 
solitary and localized to the trachea. Fiberoptic bron- 
choscopy failed to provide the diagnosis, and rigid 
bronchoscopy was required to obtain adequate tissue 
samples. The lesions were both described as diffuse 
large cell immunoblastic lymphoma. This case is, to 
our knowledge, the first to describe multiple endo- 
bronchial tumours secondary to intermediate grade 
NHL in an AIDS patient whereby the diagnosis was 
made by fiberoptic bronchoscopy. The inability to 
reach a diagnosis by fiberoptic bronchoscopy in the 
two previous case reports could be attributed to the 
high propensity of these tumours to develop necrosis, 
notably the high grade cell type. In all three cases, 
including this one, the bronchoscopic findings were 
out of proportion to those of chest radiography. The 
characteristics of the endobronchial tumours pre- 
sented in this case namely the friability and the 
vascularity, carry a large resemblance to similar 
lesions described in non-HIV-infected patients with 
multiple endobronchial lymphoma (11). The most 
common sites of endobronchial involvement in these 
cases were the main bronchi, the lobar bronchi and 
the trachea, respectively. The presenting symptoms 
were dyspnoea, cough, wheezing, stridor and haemo- 
ptysis. In a minority of patients there were 
minimal or no respiratory symptoms (12). 
Our patient improved clinically after initiation of 
chemotherapy. A follow-up chest roentgenogram 
revealed complete resolution of the right hilar in- 
filtrate. A repeat bronchoscopy was not performed. 
The overall prognosis in patients with AIDS-related 
lymphoma seems to correlate best with the CD4 
count. Karnofsky performance score less than 70%, 
diagnosis of AIDS prior to lymphoma, and bone 
marrow involvement are independently associated 
with shorter survival (3). Unfortunately, successful 
treatment with combination chemotherapy are often 
cut short by HIV-related illnesses. 
This case illustrates the need to include NHL in the 
different diagnosis of multiple endobronchial lesions 
in HIV-infected patients, and the potential wide- 
spread endobronchial disease in face of minimal chest 
radiographic or clinical abnormalities. 
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